- Previous Close
6,732.15 - Open
6,675.05 - Bid --
- Ask --
- Day's Range
6,660.05 - 6,774.95 - 52 Week Range
5,693.20 - 7,545.35 - Volume
312,265 - Avg. Volume
379,782 - Market Cap (intraday)
959.24B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
73.41 - EPS (TTM)
90.88 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield 18.00 (0.27%)
- Ex-Dividend Date Feb 14, 2025
- 1y Target Est
7,813.97
Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.
www.apollohospitals.com83,147
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: APOLLOHOSP.NS
View MorePerformance Overview: APOLLOHOSP.NS
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: APOLLOHOSP.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: APOLLOHOSP.NS
View MoreValuation Measures
Market Cap
967.98B
Enterprise Value
1.01T
Trailing P/E
73.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.62
Price/Book (mrq)
12.90
Enterprise Value/Revenue
4.81
Enterprise Value/EBITDA
33.84
Financial Highlights
Profitability and Income Statement
Profit Margin
6.20%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
211.46B
Net Income Avi to Common (ttm)
13.1B
Diluted EPS (ttm)
90.88
Balance Sheet and Cash Flow
Total Cash (mrq)
29.08B
Total Debt/Equity (mrq)
93.13%
Levered Free Cash Flow (ttm)
--